Boston Scientific Corporation (BSX-PA) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Marlborough, MA, 미국. 현재 CEO는 Michael F. Mahoney.
BSX-PA 을(를) 보유 IPO 날짜 2020-05-22, 45,000 명의 정규직 직원, 에 상장 NYSE, 시가총액 $175.45B.
Boston Scientific Corporation is a global medical device manufacturer that develops, manufactures, and markets innovative interventional medical technologies across three primary segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company's product portfolio spans diagnostic and therapeutic devices for gastrointestinal, pulmonary, urological, and cardiac conditions, as well as implantable systems such as pacemakers, defibrillators, and spinal cord stimulators for chronic pain management. Its cardiovascular offerings include drug-eluting stents, ablation catheters, coronary intervention products, and structural heart therapies, while its oncology solutions comprise embolization devices, ablation systems, and targeted delivery catheters. Headquartered in Marlborough, Massachusetts, and incorporated in 1979, Boston Scientific serves healthcare markets worldwide with a comprehensive range of medical technologies designed to improve patient outcomes across multiple therapeutic areas.
